Stevanato Group S.P.A. (STVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STVN | ORKA | AMRX | ||
| Company | Stevanato Group S.P.A. | Oruka Therapeutics Inc | Amneal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 21.46 | 106.02 | 17.07 | ||
| High | 21.55 | 109.69 | 17.80 | ||
| Low | 20.97 | 105.10 | 16.87 | ||
| Last | 21.07 | 109.48 | 17.74 | ||
| Change | -0.45 | +1.36 | +0.47 | ||
| Percent Change | -2.09% | +1.26% | +2.72% | ||
| Volume | 254,460 | 677,365 | 671,946 | ||
| 20-Day Average Volume | 424,152 | 772,508 | 1,805,998 | ||
| Previous | 21.52 | 108.12 | 17.27 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 20.17 | 97.38 | 18.08 | ||
| 20-Day Raw Stochastic | 77.48% | 98.19% | 35.54% | ||
| 20-Day Relative Strength | 59.70 | 69.57 | 52.97 | ||
| Weighted Alpha | +1.93 | +529.90 | +87.10 | ||
| Today's Opinion | 88% Buy | 100% Buy | 80% Buy | ||
| Yesterday's Opinion | 88% Buy | 100% Buy | 80% Buy | ||
| Last Month's Opinion | 56% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.48% since 08/07/26 | +10.54% since 08/07/26 | -2.67% since 08/07/26 | ||
| Low | 19.99 on 08/10/26 | 95.50 on 08/10/26 | 16.77 on 08/12/26 | ||
| High | 21.61 on 08/13/26 | 109.68 on 08/14/26 | 18.19 on 08/10/26 | ||
| 1-Month | |||||
| %Chg | +5.83% since 07/14/26 | +24.89% since 07/14/26 | +5.78% since 07/14/26 | ||
| Low | 18.74 on 07/16/26 | 80.72 on 07/17/26 | 16.70 on 07/15/26 | ||
| High | 21.61 on 08/13/26 | 109.68 on 08/14/26 | 19.26 on 07/29/26 | ||
| 3-Month | |||||
| %Chg | +16.59% since 05/14/26 | +70.95% since 05/14/26 | +44.36% since 05/14/26 | ||
| Low | 16.27 on 06/16/26 | 53.62 on 06/01/26 | 11.76 on 05/19/26 | ||
| High | 21.61 on 08/13/26 | 109.68 on 08/14/26 | 19.26 on 07/29/26 | ||
| 6-Month | |||||
| %Chg | +31.01% since 02/13/26 | +239.15% since 02/13/26 | +19.13% since 02/13/26 | ||
| Low | 12.89 on 03/27/26 | 31.08 on 02/19/26 | 11.71 on 03/24/26 | ||
| High | 21.61 on 08/13/26 | 109.68 on 08/14/26 | 19.26 on 07/29/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,517,181 | 7,158,625 | 5,509,528 | ||
| Shares Outstanding, K | 302,843 | 66,210 | 319,023 | ||
| Annual Sales, $M | 1,342,160,000 | 0 | 3,018,760,000 | ||
| Annual Net Income, $M | 158,210,000 | -105,430,000 | 72,060,000 | ||
| Last Qtr Sales, $M | 351,140,000 | 0 | 796,200,000 | ||
| Last Qtr Income, $M | 26,690,000 | -31,820,000 | 57,660,000 | ||
| 60-Month Beta | 0.77 | -0.34 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.16 on 08/04/26 | -0.55 on 08/10/26 | 0.30 on 07/30/26 | ||
| Latest Earnings Date | 11/05/26 | 11/11/26 | 10/29/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 32.20 | 0.00 | 20.53 | ||